DENVER and BETHESDA, Md., April 19, 2016 /PRNewswire/ -- As part of its ongoing mission to reach as many patients as possible with its trusted cannabis products, Mary’s Medicinals today announced that it has agreed to distribute products in Maryland through retail applicant Bethesda Biomedical.
“Having recently won Most Innovative Product at CannAwards 2015 and the 2015 Stevie American Business Award for Best Health & Pharmaceuticals Product, there was no doubt that I wanted to continue to partner with Mary’s,” said Brian Caldwell, President of Bethesda Biomedical. “Their commitment to quality, reliable, and locally sourced products is a tenet of what Bethesda Biomedical was founded on and I look forward to continuing my relationship with them on the East Coast.”
Since September 2014, Brian Caldwell has carried Mary’s Medicinals in his Washington State medical dispensary. Patients have long since come to rely on Mary’s precisely dosed transdermal patches, capsules and compounds which are reported to bring relief to many ailments and chronic pains.
Mary’s Medicinals has established itself as one of the most trusted and innovative producers of canna-based products in Colorado, and has since expanded into Arizona, Oregon, California, Vermont and Washington. Mary’s was first to offer THCa and CBN products; discovered harvesting techniques for the isolation of CBC, and continues to develop cutting edge approaches for isolating, manufacturing and delivering medicinal cannabis.
Available in THC Indica, THC Sativa, THCa, CBN, CBD and CBD/THC, Mary’s award-winning patches utilize the highest-quality, locally-sourced cannabis. The patches provide patients with up to 12 hours of reliable relief. With the knowledgeable leadership team of Bethesda Biomedical, patients will be well served with high quality products that Mary’s has perfected.
Mary’s also manufactures a line of complementary transdermal gels, compound, capsules and other products that will be available in Maryland.
About Bethesda Biomedical:
Bethesda Biomedical is a Public Benefit Corporation serving the state of Maryland by providing pharmaceutical grade cannabinoid therapies. Bethesda Biomedical will pursue socially responsible business practices, in addition to profits, by providing individuals and communities with beneficial products and services, creating economic opportunity for individuals and communities beyond the creation of jobs in the normal course of business, improving human health, and promoting science and the advancement of cannabis knowledge. More information is available at: http://www.bethesdabiomedical.com
About Mary’s Medicinals:
Mary’s Medicinals is a wellness company innovating at the intersection of engineering and horticulture. Mary’s is focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care. More information is available at: www.marysmedicinals.com
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.
Supporting Resources:
- Follow @Bethesda Biomedical on Facebook: https://www.facebook.com/bethesdabiomed/
- Follow @Marysmedicinals on:
- Media Kit
Press Contact:
Graham Sorkin
graham@marysmedicinals.com
855-420-6334
Logo - http://photos.prnewswire.com/prnh/20160418/356837LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/marys-medicinals-signs-exclusive-distribution-agreement-with-bethesda-biomedical-to-bring-transdermal-cannabis-products-to-maryland-300253498.html
SOURCE Marys Medicinals
